4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-25-209062
Chief Executive Officer sold 76,420 shares at an average $26.32 ($2,011,197)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ceesay Abraham Chief Executive Officer | 2025-09-17 | Sale 10b5-1 | −39,435 | $26.30 | $1,037,101 | 586,812 | D |
| Ceesay Abraham Chief Executive Officer | 2025-09-17 | Sale 10b5-1 | −1,400 | $26.87 | $37,624 | 585,412 | D |
| Ceesay Abraham Chief Executive Officer | 2025-09-17 | Sale 10b5-1 | −34,885 | $26.30 | $917,542 | 46,844 | I |
| Ceesay Abraham Chief Executive Officer | 2025-09-17 | Sale 10b5-1 | −700 | $27.04 | $18,930 | 46,144 | I |
| Open-market sales · 76,420 sh · avg $26.32 · $2,011,197 | |||||||
Loading xslF345X05/ownership.xml…